Adherence to Antipsychotic and Nonpsychiatric Medications in Middle-Aged and Older Patients With Psychotic Disorders
- 1 January 2003
- journal article
- conference paper
- Published by Wolters Kluwer Health in Psychosomatic Medicine
- Vol. 65 (1) , 156-162
Abstract
Objective The prevalence and consequences of nonadherence to antipsychotic medications in schizophrenia and related psychotic disorders have been well described; however, little is known about adherence to medications for nonpsychiatric conditions in patients with psychotic disorders. We wished to determine medication adherence in nondemented middle-aged and older Veterans Affairs outpatients with schizophrenia or other psychotic disorders who had been prescribed oral medications for hypertension, hyperlipidemia, or diabetes. Methods Medication adherence was assessed by review of medication fill records for 76 patients aged 40 years and older who had been prescribed an oral antipsychotic in addition to an oral agent for hypertension (N = 60), hyperlipidemia (N = 28), or diabetes (N = 24). Up to 12 months of therapy was reviewed, and a compliant fill rate (the number of adherent fills in proportion to the total number of prescription fills) and cumulative mean gap ratio (the number of days when medication was unavailable in relation to the total number of days) were calculated for each medication. Results The 12-month mean compliant fill rates for antipsychotics, antihypertensives, antihyperlipidemics, and antidiabetics ranged from 52% to 64%. Nonpsychiatric medication adherence rates were similar in patients on typical vs. atypical antipsychotics and did not correlate significantly with antipsychotic adherence rates. Conclusions Nonadherence rates were found to be equally problematic for both antipsychotic and nonpsychiatric medications in middle-aged and older patients with psychotic disorders. Interventions to improve adherence to both antipsychotic and nonpsychiatric medications are needed.Keywords
This publication has 45 references indexed in Scilit:
- Compliance With Medication Regimens for Mental and Physical DisordersPsychiatric Services, 1998
- Measurement and Management of Hyperlipidemia for the Primary Prevention of Coronary Heart DiseaseThe Journal of the American Board of Family Medicine, 1998
- Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitusThe Lancet, 1997
- Determinants of Medication Compliance in Schizophrenia: Empirical and Clinical FindingsSchizophrenia Bulletin, 1997
- Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and hypertension (AASK) pilot studyAmerican Journal of Hypertension, 1996
- Medical Comorbidity in SchizophreniaSchizophrenia Bulletin, 1996
- Measuring the Costs of SchizophreniaPharmacoEconomics, 1995
- Cost of Relapse in SchizophreniaSchizophrenia Bulletin, 1995
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Somatic illness in psychiatric patientsPsychosomatics, 1980